Comparison the effect of Trachyspermum ammi with mefenamic acid on primary dysmenorrhea

Comparison the effect of Trachyspermum ammi with mefenamic acid on primary dysmenorrhea: A randomized clinical trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180805040697N1

Enrollment

Registered

2019-04-01

Start date

2018-09-23

Completion date

Unknown

Last updated

2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Dysmenorrhea. Pain and other conditions associated with female genital organs and menstrual cycle

Interventions

Intervention 1: Intervention group: Receiving 500 mg capsules containing seeds powder TDS, from 4 days before mensturation until the third day. Intervention 2: Control group: Receiving Mefenamic acid

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: modorate to severe dysmenorrhea according to Verbal Multidimentional Scoring System exclude secondry dysmenorrhea by history taking and confirmation of primary dysmenorrhea diagnosis Regular cycles with a maximum of 3 to 4 days of priority or delay

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Primary Dysmenorrhoea. Timepoint: The day before menstruation and the first three days of menstruation in three consecutive cycles. Method of measurement: Visual Analog Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Zali

Iran University of Medical Sciences

fatemehzali@yahoo.com+98 21 5563 9667

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026